Valeant Pharmaceuticals issued its delayed annual report on Friday, which will help it stave off a default on its $30 billion debt.
Diagnostic test maker Alere said it has rejected a request by Abbott Laboratories to terminate the $5.8 billion deal to buy Alere for a breakup fee.
Mallya, currently in exile in the U.K., said he wants to settle at a reasonable number that his company can afford, the FT reports.
Broadspectrum agreed to support a bid from Ferrovial after PNG vowed to shut the detention camp operator's operations there.
Get the best of CNBC in your inbox